Clinical trial
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
NCT05934487
Study timeline
Study start (actual)2023-11-29Date precision: day
Registry last updated2026-06-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
Sponsors & collaborators
Endotronix, Inc.lead sponsor
Mapped research locations
New YorkNew York, United States3BostonMassachusetts, United States2DallasTexas, United States2CincinnatiOhio, United States2PortlandOregon, United States2DurhamNorth Carolina, United States2HoustonTexas, United States1Los AngelesCalifornia, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San AntonioTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05934487 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.